OVID
Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Ovid Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 20.3M, a 15.32% decrease year-over-year.
- Ovid Therapeutics Inc. total liabilities for 2025 were 20.3M, a 15.32% decrease from 2024.
- Ovid Therapeutics Inc. total liabilities for 2024 were 23.9M, a 57.42% decrease from 2023.
- Ovid Therapeutics Inc. total liabilities for 2023 were 56.2M, a 144.55% increase from 2022.
- Ovid Therapeutics Inc. total liabilities for 2022 were 23.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Ovid Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $20 |
| 2024 | $24 |
| 2023 | $56 |
| 2022 | $23 |
| 2021 | $15 |
| 2020 | $32 |
| Ovid Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $20 |
| 2024-12-31 | $24 |
| 2023-12-31 | $56 |
| 2022-12-31 | $23 |
| 2021-12-31 | $15 |
| 2020-12-31 | $32 |
Ovid Therapeutics Inc. Total Liabilities — FAQ
Ovid Therapeutics Inc. (OVID) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OVID's total liabilities history?
The chart and table above show Ovid Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.